# Phase 3 Source Evidence Review - Semiramis / Shakespeare / Shuten / Sitonai / Skadi (R)

- Role: R - independent reviewer
- S candidate: `382f6b56cd1180c381b8e857867a8a8d3b6841a4`
- A audit: `7786ad0ad493321b0f0b34d631e6cdacf6ee190e`
- Prior accepted R: `e7c060d7413ab2792a649033c5a320eb38bde919`
- Locked Reference: `b2f9fa15fba07c63530bbf4612b03b8b704755f9`

## Reviewer checks

- A delta from S is report-only.
- Deterministic regeneration: zero diff.
- Source-grounded: **905 / 944**
- Blocked: **39**
- Classification totals: `READY_EXISTING_CONTRACT=2`, `READY_GENERIC_EXTENSION=251`, `SPECIAL_HANDLER_CANDIDATE=652`
- Batch classification independently reproduced: **2 generic + 13 reviewed-special**.
- Audit: `EXACT_AGREEMENT`, `gapCount=0`, `zeroSilentFallback=true`.

## Validation

- `npm.cmd run typecheck` - PASS
- Phase 3 focused six - **172 / 172 PASS**
- `npm.cmd run test:ci -- --maxWorkers=2` - **617 / 617 PASS**
- `git diff --check` - PASS
- Production runtime diff vs prior accepted R under `packages src` - **none**

## Decision

**ACCEPTED.** This R closes the 15-ID Semiramis / Shakespeare / Shuten / Sitonai / Skadi source-evidence batch without runtime migration.
